However, none of these compounds have been tested in human Alzheimer patients, and the transition from animal models to human clinical outcomes is notoriously difficult in neurodegenerative disease
(In fact, no oral semaglutide medication has ever been FDA-approved for weight loss.) WIRED tested these processes from Illinois
Immune abnormalities in autism spectrum disordercould they hold promise for causative treatment
Summary A new study shows stopping GLP-1 weight loss drugs before or early in pregnancy may increase risks of weight gain, diabetes, high blood pressure, and preterm birth
Bai L, Mesgarzadeh S, Ramesh KS, Huey EL, Liu Y, Gray LA, Aitken TJ, Chen Y, Beutler LR, Ahn JS, Madisen L, Zeng H, Krasnow MA, Knight ZA
Alcohol dehydrogenase-1B genotype (rs1229984) is a strong determinant of the relationship between body weight and alcohol intake in Japanese alcoholic men